@article{ATM30842,
author = {Jaleh Fallah and Manmeet S. Ahluwalia},
title = {The role of immunotherapy in the management of patients with renal cell carcinoma and brain metastases},
journal = {Annals of Translational Medicine},
volume = {7},
number = {Suppl 8},
year = {2019},
keywords = {},
abstract = {Patients with metastatic renal cell carcinoma (mRCC) who have metastases to the brain have poor prognosis and median overall survival (OS) of 6 to 10 months (1,2). Local treatments such as surgical resection, stereotactic radiosurgery (SRS) and whole brain radiation therapy (WBRT) are the mainstay of treatment in these patients.},
issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/30842}
}